Yusuke Kimishima Selected Research

Liver Diseases (Liver Disease)

1/2018

Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yusuke Kimishima Research Topics

Disease

7	Heart Failure 01/2022 - 06/2018
4	Neoplasms (Cancer) 01/2022 - 01/2020
2	Hypertrophy 10/2023 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 01/2022
2	Hemorrhage 01/2022 - 08/2020
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2021 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2021 - 01/2020
2	Death (Near-Death Experience) 06/2021 - 01/2020
2	Pulmonary Hypertension 01/2020 - 01/2018
1	Pseudopseudohypoparathyroidism 10/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2023
1	Chest Pain (Chest Pains) 10/2023
1	Acute Coronary Syndrome 10/2023
1	Vascular Diseases (Vascular Disease) 01/2022
1	Hypoxia (Hypoxemia) 10/2021
1	Osteoporosis 04/2021
1	Bone Resorption 04/2021
1	Thrombophilia 02/2021
1	Essential Thrombocythemia 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2021
1	Atrial Fibrillation 10/2020
1	Stroke (Strokes) 10/2020
1	Myocardial Infarction 08/2020
1	Hereditary Hemorrhagic Telangiectasia 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Apnea 01/2020
1	Amyloidosis 09/2019
1	Immunoglobulin Light-chain Amyloidosis 09/2019
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Muscular Diseases (Myopathy) 01/2018

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 02/2021 - 05/2019
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020 - 09/2019
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2022
1	SteroidsIBA 10/2023
1	Adenosine Monophosphate (AMP)IBA 10/2023
1	5-phenylpent-4-enyl-1-hydroperoxideIBA 10/2023
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2023
1	Histones (Histone)IBA 10/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2023
1	Angiotensin IIIBA 10/2023
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Tacrolimus Binding Proteins (FKBP)IBA 11/2021
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 11/2021
1	Pancreatic Elastase (Elastase)IBA 10/2021
1	ChemokinesIBA 10/2021
1	Tartrate-Resistant Acid PhosphataseIBA 04/2021
1	fibrinmonomerIBA 02/2021
1	FibrinIBA 02/2021
1	CalreticulinIBA 01/2021
1	AlbuminsIBA 12/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2020
1	activin receptor type II-A (activin A receptor, type II)IBA 01/2020
1	BenzodiazepinesIBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	SodiumIBA 01/2020
1	Zolpidem (Ambien)FDA LinkGeneric 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Troponin IIBA 01/2020
1	Eszopiclone (Lunesta)FDA Link 01/2020
1	zopiclone (Zop)IBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 09/2019
1	Immunoglobulins (Immunoglobulin)IBA 09/2019
1	Amyloid (Amyloid Fibrils)IBA 09/2019
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2019
1	Neprilysin (Neutral Endopeptidase)IBA 05/2019
1	ZincIBA 06/2018
1	Collagen Type IV (Type IV Collagen)IBA 01/2018
1	ConnectinIBA 01/2018

Therapy/Procedure

4	Percutaneous Coronary Intervention 01/2022 - 08/2020
2	Therapeutics 10/2023 - 08/2020
2	Patient Readmission 06/2021 - 01/2020
1	Stents 08/2020